John Leonard, Director of the Center for Blood Cancers and Chief of the Division of Hematology and Medical Oncology at NYU Langone Health, shared a post on X:
“The STAMP trial (EA6174) is the largest clinical study (sponsored by National Cancer Institute, ECOG-ACRIN Cancer Research Group) evaluating immunotherapy as an adjuvant treatment for Merkel cell carcinoma (MCC) after surgery. Hear Janice Mehnert describe the findings presented at ASCO26.”
Other articles featuring John Leonard on OncoDaily.